Nirvana Biogenics

ViaDerma, Inc. is a Las Vegas-based company that specializes in innovative technologies within the health and wellness sector. The company focuses on advanced solutions to enhance personal care and improve overall well-being. With a commitment to innovation, ViaDerma aims to provide effective products that cater to the needs of consumers. Their dedication to quality and technological advancement positions them as a notable player in the industry. Generated from the website

Ligand Pharmaceuticals Inc., based in Las Vegas, NV, specializes in healthcare investing with a focus on the clinical development and commercialization of high-value medicines. The company manages a diverse portfolio of biopharmaceutical royalties encompassing over 90 partnered commercial and developmental programs across various disease areas, including cancer, kidney disease, and diabetes. In addition to its extensive royalty portfolio, Ligand develops and licenses innovative technology platforms, such as Captisol and NITRICIL, which are applicable in drug development. The company holds economic rights to more than 30 commercial programs marketed in over 70 countries, showcasing its prominent role in the biopharmaceutical industry. Generated from the website

Novum Pharmaceutical Research Services is a distinguished contract research organization (CRO) with over 50 years of experience in delivering comprehensive clinical research solutions to the global biotech and pharmaceutical industries. Acquired by Lambda Therapeutic Research in 2019, Novum operates under a unified brand, leveraging a vast network and substantial therapeutic expertise to effectively manage multi-centric clinical programs across various therapeutic areas. With a robust track record of FDA approvals, Novum offers end-to-end services that encompass early-phase to late-phase clinical trial management, scientific affairs, and bioanalytical support. The company is committed to upholding the highest standards of integrity and innovation while consistently exceeding client expectations in drug development programs. Generated from the website